Franklin, Parlapiano, Turner & Welch’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.72M Buy
85,942
+1,098
+1% +$88.6K 1.52% 23
2026
Q1
$7.11M Sell
84,844
-277
-0.3% -$26.5K 1.69% 22
2025
Q4
$8.24M Sell
85,121
-1,758
-2% -$171K 2.05% 15
2025
Q3
$8.27M Sell
86,879
-1,757
-2% -$162K 2.09% 14
2025
Q2
$7.73M Buy
88,636
+481
+0.5% +$40.8K 2.02% 16
2025
Q1
$7.92M Buy
88,155
+830
+1% +$74.3K 2.14% 17
2024
Q4
$6.98M Buy
87,325
+702
+0.8% +$60.8K 1.89% 21
2024
Q3
$7.8M Buy
86,623
+1,840
+2% +$155K 2.02% 19
2024
Q2
$6.67M Buy
84,783
+820
+1% +$67.2K 1.85% 23
2024
Q1
$7.32M Buy
83,963
+795
+1% +$67.8K 2.01% 23
2023
Q4
$6.85M Buy
83,168
+3,179
+4% +$242K 1.96% 24
2023
Q3
$6.27M Buy
79,989
+1,996
+3% +$167K 1.95% 23
2023
Q2
$6.87M Buy
77,993
+1,880
+2% +$162K 2.04% 24
2023
Q1
$6.14M Sell
76,113
-1,082
-1% -$88.2K 1.95% 24
2022
Q4
$6M Buy
77,195
+6,876
+10% +$557K 1.97% 23
2022
Q3
$5.68M Buy
70,319
+5,368
+8% +$482K 2.02% 22
2022
Q2
$5.83M Buy
64,951
+2,122
+3% +$215K 1.97% 22
2022
Q1
$6.97M Buy
62,829
+4,607
+8% +$487K 2.07% 18
2021
Q4
$6.02M Buy
58,222
+1,957
+3% +$227K 1.73% 24
2021
Q3
$7.05M Sell
56,265
-267
-0.5% -$34.6K 2.21% 13
2021
Q2
$7.02M Sell
56,532
-17
-0% -$2.13K 2.17% 16
2021
Q1
$6.68M Buy
56,549
+1,094
+2% +$128K 2.25% 17
2020
Q4
$6.5M Sell
55,455
-473
-0.8% -$52.1K 2.35% 13
2020
Q3
$5.81M Buy
55,928
+299
+0.5% +$30K 2.35% 13
2020
Q2
$5.1M Sell
55,629
-1,412
-2% -$135K 2.11% 17
2020
Q1
$5.14M Buy
57,041
+564
+1% +$60K 2.36% 14
2019
Q4
$6.41M Sell
56,477
-1,459
-3% -$160K 2.41% 11
2019
Q3
$6.29M Sell
57,936
-527
-0.9% -$55K 2.45% 10
2019
Q2
$5.69M Sell
58,463
-488
-0.8% -$44.6K 2.23% 17
2019
Q1
$5.37M Sell
58,951
-289
-0.5% -$25.9K 2.12% 19
2018
Q4
$5.39M Buy
59,240
+985
+2% +$92K 2.37% 12
2018
Q3
$5.73M Buy
58,255
+130
+0.2% +$12K 2.29% 13
2018
Q2
$4.98M Buy
58,125
+644
+1% +$53.8K 2.05% 14
2018
Q1
$4.61M Buy
57,481
+460
+0.8% +$37.9K 1.97% 18
2017
Q4
$4.6M Buy
57,021
+1,755
+3% +$141K 1.89% 21
2017
Q3
$4.3M Buy
55,266
+2,340
+4% +$194K 1.85% 21
2017
Q2
$4.7M Sell
52,926
-167
-0.3% -$14.1K 2.15% 13
2017
Q1
$4.28M Buy
53,093
+2,326
+5% +$182K 1.99% 17
2016
Q4
$3.62M Buy
50,767
+711
+1% +$55.9K 1.8% 21
2016
Q3
$4.33M Buy
50,056
+2,127
+4% +$185K 2.2% 9
2016
Q2
$4.16M Sell
47,929
-2,386
-5% -$193K 2.22% 9
2016
Q1
$3.77M Buy
50,315
+2,094
+4% +$158K 2.08% 14
2015
Q4
$3.71M Buy
48,221
+1,626
+3% +$122K 2.2% 11
2015
Q3
$3.12M Sell
46,595
-437
-0.9% -$32.2K 2.05% 14
2015
Q2
$3.48M Buy
47,032
+818
+2% +$62.5K 2.31% 10
2015
Q1
$3.6M Sell
46,214
-2,266
-5% -$172K 2.42% 7
2014
Q4
$3.5M Buy
48,480
+1,184
+3% +$82.2K 2.34% 8
2014
Q3
$2.93M Buy
47,296
+1,476
+3% +$93.8K 2.1% 12
2014
Q2
$2.92M Buy
45,820
+1,052
+2% +$63.9K 2.09% 11
2014
Q1
$2.75M Sell
44,768
-1,363
-3% -$79.4K 1.99% 9
2013
Q4
$2.65M Buy
46,131
+1,004
+2% +$56.9K 1.83% 12
2013
Q3
$2.4M Buy
45,127
+6,023
+15% +$324K 1.76% 12
2013
Q2
$2.01M Buy
+39,104
New +$1.93M 1.72% 15

Other funds holding MDT

Franklin, Parlapiano, Turner & Welch's MDT Position: Q2 2026 in Review

Franklin, Parlapiano, Turner & Welch increased its Medtronic (MDT) stake by 1.3% in Q2 2026, buying an estimated $88.6K and bringing the position to 85,942 shares worth $6.72M. The position accounts for 1.52% of the portfolio, ranked #23.

Franklin, Parlapiano, Turner & Welch first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.27M in Q3 2025. 545 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Franklin, Parlapiano, Turner & Welch held 85,942 shares of Medtronic worth $6.72M as of Q2 2026.
  • Franklin, Parlapiano, Turner & Welch bought 1,098 Medtronic shares in Q2 2026, an estimated $88.6K.
  • Medtronic made up 1.52% of Franklin, Parlapiano, Turner & Welch's portfolio in Q2 2026, its #23 holding.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Franklin, Parlapiano, Turner & Welch's Medtronic position peaked at $8.27M in Q3 2025.
  • 545 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2026, filed 9 Jul 2026.